The Board of Partners of E. Merck KG has appointed two new members of the Executive Board of Merck KGaA, Darmstadt, Germany: As of April 30, 2016, Udit Batra, Head of the Life Science business
sector, and Walter Galinat, Head of the Performance Materials business sector, will become new members of the Executive Board while retaining their previous business responsibilities.
Bernd Reckmann, currently the Executive Board member responsible for Life Science and Performance Materials, will retire on conclusion of the Annual General Meeting on April 29, 2016.
Walter Galinat joined Merck KGaA in 1976 as an apprentice. After earning a degree in Business Administration, in 1984 he moved to Taiwan, where he built up the local subsidiary of Merck KGaA, Darmstadt, Germany. He
returned to Germany in 1994, became head of the Laboratory Products division, and in 1996 assumed the leadership of Eurolab, the company’s former laboratory distribution business. He was appointed head of the former Liquid Crystals division in 2007 and became CEO and President of today’s Performance Materials business sector in 2010.
Udit Batra was awarded a PhD in Chemical Engineering from Princeton University and started his career at MSD in 1996. Prior to joining Merck KGaA, Darmstadt, Germany, Batra worked for Novartis as Head of Global Public Health and Market Access for Vaccines and Diagnostics, as Global Head of Corporate Strategy, and as Country President of the pharmaceutical business in Australia. He joined Merck KGaA, Darmstadt, Germany, in 2011, taking over the leadership of the Consumer Health business. In March 2014, he was appointed CEO and President of the company’s Life Science business.
Source: Merck KGaA